Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists
(MedPage Today) -- ANAHEIM, Calif. -- Insurance coverage and out-of-pocket costs for GLP-1 receptor agonists pose serious barriers to patients prescribed these drugs for type 2 diabetes and other indications, two single-site studies showed....
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Insurance | Study